IO Biotech, Inc.

IOBT

IO Biotech, Inc.

IOBT

Insider Sentiment (TTM):

Last Purchase:2025-05-30Last Sale:2024-07-26Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:7,829,105Shares Outstanding:66,941,964Institutional Ownership Pct.:11.70%

Earnings Market Reaction:

Filing Date:2025-11-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	31	28	37	60	80	101	118	143	166	110	129	143
Prepaid Expense And Other Assets Current	6	11	5	5	6	7	6	4	3	3	4	6
Assets Current	37	39	42	65	86	108	124	147	168	113	132	148
Restricted Cash Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	1	1	1
Operating Lease Right Of Use Asset	1	1	2	2	2	2	2	2	2	3	3	2
Other Assets Noncurrent	1	1	1	0	1	1	1	0	1	1	1	0
Assets Noncurrent	3	3	3	3	4	4	4	3	4	5	5	4
Assets	40	42	46	68	90	111	128	151	173	118	137	152
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	6	6	5	5	5	5	4	4	7	4	4	4
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Accrued Liabilities And Other Liabilities	12	14	12	14	10	8	7	11	6	6	6	6
Liabilities Current	18	20	18	19	16	14	11	16	13	11	10	11
Operating Lease Liability Noncurrent	1	1	1	1	1	1	2	2	2	2	2	2
Long Term Debt Noncurrent	17	7	-	-	-	-	-	-	-	-	-	-
Liabilities Noncurrent	21	21	1	1	1	1	2	2	2	2	2	2
Liabilities	39	41	19	21	17	15	13	18	15	13	13	13
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	424	416	415	413	411	410	408	407	405	330	329	327
Retained Earnings Accumulated Deficit	-416	-408	-382	-359	-328	-304	-283	-264	-238	-216	-195	-178
Accumulated Other Comprehensive Income Loss Net Of…	-7	-7	-7	-7	-11	-10	-9	-10	-10	-10	-10	-10
Stockholders Equity	1	2	26	47	73	96	115	133	158	105	124	139
Liabilities And Stockholders Equity	40	42	46	68	90	111	128	151	173	118	137	152
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	70	66	66	66	66	66	66	66	66	29	29	29
Shares Outstanding	70	66	66	66	66	66	66	66	66	29	29	29

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	63.27%	52.04%	126.53%	52.34%	-62.34%	-18.75%	-15.82%	-18.91%	-64.95%	-	-	-
2024	-14.38%	-16.67%	-15.28%	-44.84%	-24.84%	-21.57%	-7.27%	0.84%	-2.95%	-11.93%	11.01%	19.27%
2023	-6.05%	-9.07%	-13.49%	-1.09%	-22.95%	-53.83%	33.66%	106.27%	92.06%	6.79%	-12.35%	-21.60%
2022	-	-	-	-	-	-	-	-	-	-20.90%	-11.89%	-17.21%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	2.01	1.96	2.32	3.33	5.37	7.84	11.24	9.37	12.96	10.39	12.77	13.88
Quick Ratio	1.67	1.41	2.03	3.08	4.99	7.34	10.68	9.11	12.75	10.12	12.41	13.36
Working Capital	18.52M	19.08M	24.06M	45.47M	70.19M	93.93M	113.09M	131.54M	155.27M	102.16M	121.91M	137.54M
Leverage & Debt
Debt to Equity	42.86	25.59	0.73	0.44	0.24	0.16	0.11	0.13	0.09	0.12	0.10	0.09
Interest Coverage TTM	-	-	-	-	-	-	-	-	-83,648.00	-962.39	-399.66	-234.95
Debt Ratio	0.98	0.96	0.42	0.31	0.19	0.14	0.10	0.12	0.09	0.11	0.09	0.09
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.32	-1.58	-1.49	-1.45	-1.37	-1.34	-1.34	-1.98	-1.59	-2.57	-2.47	-2.48
Free Cash Flow Per Share TTM	-1.21	-1.27	-1.22	-1.25	-1.30	-1.23	-1.25	-1.66	-1.24	-2.06	-1.88	-2.10
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-2.20%	18.16%	11.25%	10.93%	12.96%	18.95%	24.12%	20.47%	-29.06%	-28.57%	-	-
EPS Growth (1Y)	-3.75%	18.16%	11.25%	-26.69%	-13.98%	-47.97%	-45.71%	-20.27%	-59.25%	-28.57%	-	-
Calculated Values
Free Cash Flow TTM	-81.07M	-83.40M	-80.55M	-82.39M	-85.66M	-80.86M	-82.17M	-72.06M	-62.03M	-59.48M	-54.30M	-60.42M
Net Debt	-14.00M	-21.41M	-37.09M	-60.03M	-80.19M	-100.75M	-117.98M	-143.19M	-165.50M	-110.10M	-128.53M	-142.59M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-05-30Purchase

Owner: Hunter, Heidi

Title: -

Shares: 15,000

Price/Share: $1.39

Value: $20,850.00

Shares Owned: 15,000

Relationship: Director

Ownership: Direct

2024-12-23Purchase

Owner: Zocca, Mai-Britt

Title: Chief Executive Officer

Shares: 12,500

Price/Share: $0.81

Value: $10,125.00

Shares Owned: 49,891

Relationship: Director,Officer

Ownership: Direct

2024-12-23Purchase

Owner: Sullivan, Amy

Title: Chief Financial Officer

Shares: 10,250

Price/Share: $0.83

Value: $8,507.50

Shares Owned: 84,632

Relationship: Officer

Ownership: Direct

2024-12-23Purchase

Owner: Ahmad, Qasim Iftikhar

Title: Chief Medical Officer

Shares: 31,350

Price/Share: $0.85

Value: $26,647.50

Shares Owned: 31,350

Relationship: Officer

Ownership: Direct

2024-12-23Purchase

Owner: Smith, Devin Whittemore

Title: General Counsel

Shares: 12,000

Price/Share: $0.81

Value: $9,720.00

Shares Owned: 16,938

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-05-30	Hunter, Heidi	Director	-	Direct	Purchase	15,000	1.39	$20,850.00	15,000	4
2024-12-23	Zocca, Mai-Britt	Director,Officer	Chief Executive Officer	Direct	Purchase	12,500	0.81	$10,125.00	49,891	4
2024-12-23	Sullivan, Amy	Officer	Chief Financial Officer	Direct	Purchase	10,250	0.83	$8,507.50	84,632	4
2024-12-23	Ahmad, Qasim Iftikhar	Officer	Chief Medical Officer	Direct	Purchase	31,350	0.85	$26,647.50	31,350	4
2024-12-23	Smith, Devin Whittemore	Officer	General Counsel	Direct	Purchase	12,000	0.81	$9,720.00	16,938	4
2024-07-26	Novo, Holdings A/S	TenPercentOwner	-	Direct	Sale	23,478	1.31	$30,756.18	4,354,449	4
2024-05-10	Novo, Holdings A/S	TenPercentOwner	-	Direct	Sale	658,809	1.22	$803,746.98	4,429,449	4
2024-02-09	Novo, Holdings A/S	TenPercentOwner	-	Direct	Sale	658,809	1.50	$988,213.50	5,088,258	4
2023-11-22	Burkavage, Brian	Officer	Chief Accounting Officer	Direct	Purchase	5,000	1.04	$5,200.00	11,500	4
2023-08-09	Novo, Holdings A/S	TenPercentOwner	-	Direct	Purchase	2,469,135	2.03	$5,012,344.05	5,707,467	4
2023-08-09	Vivo, Capital Ix, Llc, Vi…	TenPercentOwner	-	Indirect	Purchase	3,157,894	1.90	$5,999,998.60	3,157,894	4
2023-03-17	Sullivan, Amy	Officer	Chief Financial Officer	Direct	Purchase	25,000	2.32	$58,000.00	25,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

11.70%

Inst. Shares: 7,829,105

Shares Outstanding: 66,941,964

2025-09-30

14.72%

Inst. Shares: 9,856,851

Shares Outstanding: 66,941,964

2025-06-30

25.97%

Inst. Shares: 17,106,733

Shares Outstanding: 65,880,914

2025-03-31

27.30%

Inst. Shares: 17,983,158

Shares Outstanding: 65,880,914

2024-12-31

28.15%

Inst. Shares: 18,546,963

Shares Outstanding: 65,880,914

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	7,829,105	66,941,964	11.70%
2025-09-30	9,856,851	66,941,964	14.72%
2025-06-30	17,106,733	65,880,914	25.97%
2025-03-31	17,983,158	65,880,914	27.30%
2024-12-31	18,546,963	65,880,914	28.15%
2024-09-30	22,434,105	65,880,914	34.05%
2024-06-30	25,126,252	65,880,914	38.14%
2024-03-31	26,122,246	65,880,914	39.65%
2023-12-31	28,259,279	43,539,976	64.90%
2023-09-30	28,591,672	50,168,303	56.99%
2023-06-30	12,177,748	28,815,267	42.26%
2023-03-31	13,836,018	28,815,267	48.02%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

IO Biotech, Inc. (IOBT) — SEC Financial Statements & Analysis

IO Biotech, Inc. (IOBT) is a pharmaceutical preparations company, incorporated in DE. IO Biotech, Inc. trades on Nasdaq as: IOBT. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), IO Biotech, Inc. reported a Debt-to-Equity ratio of 42.86x. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 42.86x

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is IO Biotech, Inc. in?

IO Biotech, Inc. (IOBT) operates in the Pharmaceutical Preparations industry.

What exchange does IOBT trade on?

IO Biotech, Inc. (IOBT) trades on the Nasdaq.

Where is IO Biotech, Inc. incorporated?

IO Biotech, Inc. is incorporated in DE.

IO Biotech, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

IO Biotech, Inc. (IOBT) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

IO Biotech, Inc. (IOBT) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.